The bone grafts and substitutes market refers to the industry that deals with the production and distribution of materials used in bone grafting procedures. Bone grafting is a surgical procedure commonly performed to repair and replace damaged or missing bone tissue. It involves transplanting bone from one area of the body (autograft) or using synthetic or natural materials (allograft or substitutes) to stimulate bone growth and facilitate the healing process. Bone grafts and substitutes are used in various orthopedic, dental, and trauma surgeries. They are employed in procedures such as spinal fusion, joint replacement, fracture repair, and treatment of bone defects or non-union fractures. These materials provide structural support, stimulate new bone formation, and serve as a scaffold for bone regeneration.
The market for bone grafts and substitutes has experienced significant growth over the years due to several factors. These include the increasing prevalence of musculoskeletal disorders, rising geriatric population, growing demand for minimally invasive surgeries, advancements in medical technology, and the expanding applications of bone grafts and substitutes in dental and orthopedic procedures.
Download Free Sample Copy of this Report – https://www.factmr.com/connectus/sample?flag=S&rep_id=7229
Key Segments Covered in Bone Grafts and Substitutes Industry Research
- By Product:
- Allografts
- Demineralized Bone Matrix (DBM)
- Others
- Synthetic Bone Grafts
- Others
- Allografts
- By Material:
- Ceramic-based Bone Grafts and Substitutes
- Calcium Phosphate
- Calcium Sulfate
- Others
- Polymer-based Bone Grafts and Substitutes
- Polylactides
- Polyglycolides
- Polyurethanes
- Others
- Growth Factor-based Bone Grafts and Substitutes
- Cell-based Bone Grafts and Substitutes
- Others
- Ceramic-based Bone Grafts and Substitutes
- By End User:
- Hospitals
- Orthopedic Clinics
- Others
- By Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
Key Takeaways from Market Study
- Global bone grafts and substitutes market to reach a valuation of US$ 4.44 Bn by 2028.
- Market in North America holds a high share of 53.1%.
- Demand for allografts are expected to increase at a significant CAGR over the coming years.
“Rising initiatives to improve the bioactivity of bone graft substitutes, growing adoption of minimally-invasive procedures, and increasing knowledge among patients about biologic bone regeneration benefits are aspects driving market expansion,” says a Fact.MR analyst
Winning Strategy
The market is characterized by fierce competition and is dominated by a few important players. To increase revenue, key businesses are focusing on executing creative tactics such as mergers & acquisitions, market penetration, collaborations, and distribution agreements.
Key players in the market are concentrating on diversifying their product portfolios and utilizing materials with higher quality, characteristics, and functionalities.
For instance,
- In February 2021, NuVasive bought Simplify Medical to expand its cervical portfolio and expand growth prospects.
- In 2019, McGill University produced a biocompatible and hardened multilayered bone grafts for the repair of major bone lesions.
- In 2019, Bioventus launched OSTEOMATRIX+, a next-generation biphasic bone transplant for use in orthopedic and spine applications.
More Valuable Insights on Offer
Fact.MR, in its new offering, presents an unbiased analysis of the global bone grafts and substitutes market, presenting historical demand data (2017-2020) and forecast statistics for the period of 2021-2028.
The study divulges essential insights on the market on the basis of product (allografts, synthetic bone grafts, and others), by material (ceramic-based, polymer-based, growth factor-based, cell-based, and others) by end user (hospitals, orthopedic clinics, and others), across five major regions (North America, Europe, Asia Pacific, Latin America, and MEA).